PuSH - Publication Server of Helmholtz Zentrum München: Parkinson's Disease-Related pattern in isolated REM sleep behaviour disorder as a prodromal progression marker: 8-Year Follow-Up changes assessed at three time points.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Carli, G.* ; Dortmond, A.* ; Janzen, A.* ; Sittig, E.* ; De Meyer, E.* ; Leenders, K.L.* ; Oertel, W.H. ; Meles, S.K.*

Parkinson's Disease-Related pattern in isolated REM sleep behaviour disorder as a prodromal progression marker: 8-Year Follow-Up changes assessed at three time points.

Eur. J. Nucl. Med. Mol. Imaging, DOI: 10.1007/s00259-025-07260-9 (2025)

Postprint

DOI

PMC

	Open Access Green

Abstract
Metrics
Extra information

BACKGROUND: Isolated REM sleep behavior disorder (iRBD) is a prodromal stage of alpha-synucleinopathies. Biomarkers are crucial for predicting and monitoring its progression, warranting long-term neuroimaging studies. While the Parkinson's Disease Related Pattern (PDRP) from ¹⁸F-FDG PET is a recognized Parkinson's Disease (PD) biomarker, its role in tracking progression in prodromal PD remains unclear. OBJECTIVE: To explore PDRP expression across three time points using ¹⁸F-FDG PET over an 8-year follow-up in iRBD. METHODS: Thirteen iRBD subjects underwent ¹⁸F-FDG PET brain scans at baseline (BL), follow-up 1 (FU1, 4 years), and follow-up 2 (FU2, 8 years). Among them, four developed PD, one Dementia with Lewy Bodies (DLB), three showed subthreshold parkinsonism, and five showed no progression. PDRP z-scores were analyzed within and between groups (converters vs. non-converters) using a two-way repeated measures ANOVA. Similar analyses were conducted for motor scores (Unified Parkinson's Disease Rating Scale part three, UPDRS-III). RESULTS: There was a significant main effect of group (p = 0.011), time (p < 0.001), and a group*time interaction (p = 0.020), indicating that while PDRP z-scores increased over time in most iRBD subjects, the increase was more pronounced in converters (n = 5) than in non-converters (n = 8). Post-hoc tests revealed significantly higher PDRP z-scores in converters compared to non-converters at FU1 (p = 0.042) and FU2 (p = 0.024). For UPDRS-III scores we found significant effects of group (p = 0.011), time (p < 0.001), and their interaction (p = 0.0003). CONCLUSIONS: Repeated ¹⁸F-FDG PET scans may be useful to monitor prodromal disease progression and predict conversion in iRBD patients.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords 18f-fdg Pet ; Pdrp ; Brain Glucose Metabolism ; Disease Progression ; Irbd; Metabolic Network Activity; Criteria

ISSN (print) / ISBN 1619-7070

e-ISSN 1432-105X

Journal European Journal of Nuclear Medicine and Molecular Imaging

Publisher Springer

Publishing Place One New York Plaza, Suite 4600, New York, Ny, United States

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute of Neurogenomics (ING)

Grants Michael J. Fox Foundation (Edmond J. Safra Fellowship in Movement Disorders)
Charitable Hertie Foundation, Frankfurt/Main, Germany
German "ParkinsonFonds Deutschland"
Dutch "Stichting ParkinsonFonds"